These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population. Verrijken A, Beckers S, Francque S, Hilden H, Caron S, Zegers D, Ruppert M, Hubens G, Van Marck E, Michielsen P, Staels B, Taskinen MR, Van Hul W, Van Gaal L. Obesity (Silver Spring); 2013 Oct; 21(10):2138-45. PubMed ID: 23512881 [Abstract] [Full Text] [Related]
3. Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C. Zampino R, Coppola N, Cirillo G, Boemio A, Pisaturo M, Marrone A, Macera M, Sagnelli E, Perrone L, Adinolfi LE, Miraglia del Giudice E. J Viral Hepat; 2013 Aug; 20(8):517-23. PubMed ID: 23808989 [Abstract] [Full Text] [Related]
8. [Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease]. Xu J, Xin YN, Lü WH, Lin ZH, Zhang DD, Zhang M, Dong QJ, Jiang XJ, Xuan SY. Zhonghua Gan Zang Bing Za Zhi; 2013 Aug 25; 21(8):619-23. PubMed ID: 24119744 [Abstract] [Full Text] [Related]
9. Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population. Niu TH, Jiang M, Xin YN, Jiang XJ, Lin ZH, Xuan SY. World J Gastroenterol; 2014 Apr 07; 20(13):3655-62. PubMed ID: 24707151 [Abstract] [Full Text] [Related]
10. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. Hotta K, Yoneda M, Hyogo H, Ochi H, Mizusawa S, Ueno T, Chayama K, Nakajima A, Nakao K, Sekine A. BMC Med Genet; 2010 Dec 22; 11():172. PubMed ID: 21176169 [Abstract] [Full Text] [Related]
11. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. Valenti L, Rumi M, Galmozzi E, Aghemo A, Del Menico B, De Nicola S, Dongiovanni P, Maggioni M, Fracanzani AL, Rametta R, Colombo M, Fargion S. Hepatology; 2011 Mar 22; 53(3):791-9. PubMed ID: 21319195 [Abstract] [Full Text] [Related]
14. Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2. Zhou Y, Llauradó G, Orešič M, Hyötyläinen T, Orho-Melander M, Yki-Järvinen H. J Hepatol; 2015 Mar 22; 62(3):657-63. PubMed ID: 25457209 [Abstract] [Full Text] [Related]
15. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. Romeo S, Sentinelli F, Cambuli VM, Incani M, Congiu T, Matta V, Pilia S, Huang-Doran I, Cossu E, Loche S, Baroni MG. J Hepatol; 2010 Aug 22; 53(2):335-8. PubMed ID: 20546964 [Abstract] [Full Text] [Related]
16. Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis. Finkenstedt A, Auer C, Glodny B, Posch U, Steitzer H, Lanzer G, Pratschke J, Biebl M, Steurer M, Graziadei I, Vogel W, Zoller H. Clin Gastroenterol Hepatol; 2013 Dec 22; 11(12):1667-72. PubMed ID: 23872669 [Abstract] [Full Text] [Related]
19. Adipocyte size is associated with NAFLD independent of obesity, fat distribution, and PNPLA3 genotype. Petäjä EM, Sevastianova K, Hakkarainen A, Orho-Melander M, Lundbom N, Yki-Järvinen H. Obesity (Silver Spring); 2013 Jun 22; 21(6):1174-9. PubMed ID: 23913731 [Abstract] [Full Text] [Related]